RYTM RHYTHM PHARMACEUTICALS
Health Care · Russell 2000
Next earnings: not announced yet
What 24 analyst firms say about RHYTHM PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
20 rated views · 25 analyst/firm records · 24 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8079
- Russell 2000 · Safest consensus · 6MGood · #28 in the index83
Recent analyst activity · last 90 days
Our tracked history has 13 reports on RYTM from 11 analyst firms in the last 90 days (24 firms in the past year).
Comparing each firm's latest target with its previous one: 4 raised their price target, 2 lowered it and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Guggenheim raised its target from $143.00 (set 20 Mar 2026) to $147.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Tazeen Ahmad | Buy | 17 Mar 2026 | 139.00 USD |
| Canaccord Genuity | Whitney Ijem | — | 5 Aug 2026 | 154.00 USD |
| Citigroup | Samantha Semenkow | Buy | 5 Aug 2026 | 143.00 USD |
| Citizens JMP | Jonathan Wolleben | Buy | 4 Nov 2026 | 166.00 USD |
| Deutsche Bank | David Hoang | Hold | 28 Aug 2026 | 120.00 USD |
| Goldman Sachs | Corinne Jenkins | Buy | 12 Dec 2025 | 157.00 USD |
| Goldman Sachs | Corinne Johnson | Buy | 14 May 2026 | 159.00 USD |
| Guggenheim | Seamus Fernandez | Buy | 20 Mar 2026 | 143.00 USD |
| H.C. Wainwright | Raghuram Selvaraju | Buy | 12 Oct 2026 | 130.00 USD |
| Jefferies | Dennis Ding | Buy | 15 Jun 2026 | 125.00 USD |
| JPMorgan | Priyanka Grover | Buy | 15 Oct 2026 | 145.00 USD |
| Leerink Partners | Basma Radwan | Buy | 14 Sep 2026 | Conflicting reports · excluded |
| Morgan Stanley | Jeffrey Hung | Buy | 17 Mar 2026 | 136.00 USD |
| National Bank Financial | Unnamed analyst | — | 5 Aug 2026 | 160.00 USD |
| Needham | Joseph R Stringer | Buy | 15 Sep 2026 | Conflicting reports · excluded |
| RBC Capital Markets | Lisa Walter | Buy | 8 Oct 2026 | 159.00 USD |
| Stifel | Paul Matteis | — | 15 Jun 2026 | 133.00 USD |
| TD Cowen | Philip M Nadeau | Buy | 24 Mar 2026 | 130.00 USD |
| Telsey Advisory Group | Unnamed analyst | — | 12 Mar 2026 | 143.00 USD |
| UBS | Unnamed analyst | Buy | 17 Dec 2025 | — |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Derek Archila | Buy | 15 Jun 2026 | 155.00 USD |
| William Blair | Alethia Young | Buy | 16 Oct 2026 | — |
| Wolfe Research | Kalpit Patel | Buy | 17 Sep 2026 | 125.00 USD |
| Data feed RESEARCH | Research Team | Hold | 17 Feb 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:38 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.